A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : PC / peritoneal carcinomatosis

[Related PubMed/MEDLINE]
Total Number of Papers: 578
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   PC  (>> Co-occurring Abbreviation)
Long Form:   peritoneal carcinomatosis
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A precise temperature control during hyperthermic intraperitoneal chemotherapy promises an early return of bowel function. HIPEC, OS, VAS
2020 Clinical outcomes of curative treatment for colorectal liver metastases combined with cytoreductive surgery and intraperitoneal chemotherapy for peritoneal metastases: a systematic review and meta-analysis of current evidence. CI, CRC, HRs, LM, RRs
2020 Clinicopathological and Molecular Study of Peritoneal Carcinomatosis Associated with Non-Small Cell Lung Carcinoma. NGS, NSCLC
2020 Comparison of hyperthermic intraperitoneal chemotherapy regimens for treatment of peritoneal-metastasized colorectal cancer. CRC, CRS, HIPEC, MMC, PCI
2020 Comparison of the outcomes of cytoreductive surgery versus surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: a propensity score matching analysis. CRS, HIPEC, PSM
2020 Current Opinion on Peritoneal Carcinomatosis Treatment: a Survey of the Indian Society of Peritoneal Surface Malignancies (ISPSM). HIPEC, ISPSM
2020 Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy With Mitomycin C Used for Colorectal Peritoneal Carcinomatosis. CRS, HIPEC, PCI
2020 Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer: The prognostic impact of baseline neutrophil-lymphocyte, platelet-lymphocyte and lymphocyte-monocyte ratios. CC, CRC, CRS-HIPEC, LMR, NLR, OS, PCI, PLR
2020 Diagnostic performance of CT for differentiating peritoneal tuberculosis from peritoneal carcinomatosis: a systematic review and meta-analysis. AUC, PTB, SROC
10  2020 Dietary fats suppress the peritoneal seeding of colorectal cancer cells through the TLR4/Cxcl10 axis in adipose tissue macrophages. ATMs, CRC, HFD
11  2020 Distal pancreatectomy in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: Identifying risk and improving patient selection. CRS/HIPEC, DP
12  2020 Efficacy of ascitic fluid cell block for diagnosing primary ovarian, peritoneal, and tubal cancer in patients with peritoneal carcinomatosis with ascites. ACB, CNB
13  2020 Endoscopic Ultrasound-Guided Random Omental Fine Needle Aspiration: A Novel Technique for the Diagnosis of Peritoneal Carcinomatosis. EUS, EUS-FNA
14  2020 Evaluation of a Novel Prototype for Pressurized Intraperitoneal Aerosol Chemotherapy. DCD, DMD, PIPAC
15  2020 Functional tumour burden of peritoneal carcinomatosis derived from DWI could predict incomplete tumour debulking in advanced ovarian carcinoma. ADC, fPCI, OC, sPCI
16  2020 Gastric Cancer Peritoneal Carcinomatosis Risk Score. CI, GC, IQR, OR
17  2020 High-grade complication is associated with poor overall survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. CRS, HIPEC
18  2020 Identifying the incidence of respiratory complications following diaphragmatic cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy. CRS, HIPEC
19  2020 Impact of Perfusate Concentration on Hyperthermic Intraperitoneal Chemotherapy Efficacy and Toxicity in a Rodent Model. CRC, HIPEC
20  2020 Improved Survival with Experience: A 10-Year Learning Curve in Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery. CRS/HIPEC, EBL, ICU, LOS, PCI
21  2020 In vivo Spectroscopic Evaluation of the Intraperitoneal Cavity in Canines. BPD, PDT
22  2020 Influence of peritoneal carcinomatosis on perioperative outcome in palliative gastric bypass for malignant gastric outlet obstruction - a retrospective cohort study. GJJ, GOO
23  2020 Initial experience of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a French hyperthermic intraperitoneal chemotherapy (HIPEC) expert center. HIPEC, PIPAC
24  2020 Intraperitoneal CMP-001: A Novel Immunotherapy for Treating Peritoneal Carcinomatosis of Gastrointestinal and Pancreaticobiliary Cancer. ELISA, IFN-alpha, IL-6, NK, pDCs
25  2020 Iodine overlays to improve differentiation between peritoneal carcinomatosis and benign peritoneal lesions. AUC, BPA, CI, IO, SDCT
26  2020 Is ascites CEA a risk factor for peritoneal carcinomatosis in colorectal cancer?: a long-term follow-up study. CEA, CRC
27  2020 Locoregional peritoneal hyperthermia to enhance the effectiveness of chemotherapy in patients with peritoneal carcinomatosis: a simulation study comparing different locoregional heating systems. HIPEC, SAR, TER
28  2020 Management of Peritoneal Carcinomatosis With Cytoreductive Surgery Combined With Intraperitoneal Chemohyperthermia at a Novel Italian Center. CRS, GI, HIPEC, PM, QOL
29  2020 Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response. GAC, Tim-3, VISTA, WES
30  2020 N-Acetyl-l-cysteine Enhances the Effect of Selenium Nanoparticles on Cancer Cytotoxicity by Increasing the Production of Selenium-Induced Reactive Oxygen Species. NAC, ROS, SeNPs
31  2020 Novel Chimeric Immuno-Oncolytic Virus CF33-hNIS-antiPDL1 for the Treatment of Pancreatic Cancer. hNIS, i.p, MOI, PDAC, s.c
32  2020 Outcomes in Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC). CRS/HIPEC, GCA
33  2020 Ovarian cancer subtypes and survival in relation to three comprehensive imaging parameters. BD, CPLN, CT, OC
34  2020 Palliative treatment for malignant gastrointestinal obstruction with peritoneal carcinomatosis: enteral stenting versus surgery. AEs, ECOG, MGIO
35  2020 Peritoneal Carcinomatosis and Its Mimics: Review of CT Findings for Differential Diagnosis. CT
36  2020 Peritoneal carcinomatosis in gastric cancer: Are Hispanics at higher risk? NHB, NHW
37  2020 Peritoneal Carcinomatosis in Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: Clinical Impact and Effectiveness of the Available Therapeutic Options. GEP-NENs, PRRT
38  2020 Peritoneal Cell-Free Tumor DNA as Biomarker for Peritoneal Surface Malignancies. CRS, ddPCR, MAF
39  2020 Preclinical Evaluation of Cetuximab and Benzoporphyrin Derivative-Mediated Intraperitoneal Photodynamic Therapy in a Canine Model. BPD, EGFR, PDT, SBR
40  2020 Primary Peritoneal High-grade Serous Carcinoma Misinterpreted as Metastatic Breast Carcinoma: A Rare Encounter in Peritoneal Fluid Cytology. HGSC, PAX8, PF, WT1
41  2020 Prognostic Value and Risk Factors of Peritoneal Carcinomatosis Recurrence for Patients with Endometrial Cancer: A Multicenter Study from the FRANCOGYN Group. EC, FIGO, OS, OSAR, PCR
42  2020 Prophylactic HIPEC in pT4 Colon Tumors: Proactive Approach or Overtreatment? HIPEC
43  2020 Role of hyperthermic intraperitoneal chemotherapy in ovarian cancer. CRS, CT, DFS, EOC, HIPEC, OS
44  2020 ROS1-rearranged lung adenocarcinoma with peritoneal carcinomatosis on initial presentation. ROS1
45  2020 Strategies for 'bloodless' surgery: the experience of cytoreductive surgery for peritoneal carcinomatosis in Jehovah's Witnesses. CRS, HIPEC
46  2020 Study protocol of a multicenter phase III randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 gastrectomy with intraoperative HIPEC for advanced gastric cancer (AGC): dragon II trial. AC, AGC, HIPEC, NAC, NLHIPEC, NLHIPEC, OS, PFS, PMR, WHO-ICTRP
47  2020 Synergy between Intraperitoneal Aerosolization (PIPAC) and Cancer Nanomedicine: Cisplatin-Loaded Polyarginine-Hyaluronic Acid Nanocarriers Efficiently Eradicate Peritoneal Metastasis of Advanced Human Ovarian Cancer. Cis-pARG-HA NPs, PIPAC
48  2020 The importance of primary tumor origin in gastrointestinal malignancies undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. CRS/HIPEC, PCI
49  2020 The Safety of Iterative Cytoreductive Surgery and HIPEC for Peritoneal Carcinomatosis: A High Volume Center Prospectively Maintained Database Analysis. CRS/HIPEC
50  2020 YAP1 mediates gastric adenocarcinoma peritoneal metastases that are attenuated by YAP1 inhibition. CSC, GAC, PDO, PDX, RNA-Seq, scRNA-Seq, YAP1
51  2019 Aerosolization of Nanotherapeutics as a Newly Emerging Treatment Regimen for Peritoneal Carcinomatosis. i.p, PIPAC
52  2019 Alteration of Adaptive Immunity in a Colorectal Peritoneal Carcinomatosis Model. CRC
53  2019 Analysis of Bacterial and Fungal Infections after Cytoreduction Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Observational Single-Centre Study. APTT, CI, CRS, ESBL, HIPEC, HR
54  2019 Calculation of a clinical predictive factors identifying peritoneal disease on a staging laparoscopy in gastric cancers. GCs, SL
55  2019 Cost-Effectiveness Analysis of Cytoreductive Surgery and HIPEC Compared With Systemic Chemotherapy in Isolated Peritoneal Carcinomatosis From Metastatic Colorectal Cancer. CRS, HIPEC, ICER, LYs, mCRC, PSA, QALYs, WTP
56  2019 Cytoreduction plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in colorectal cancer patients: a single-center cohort study. CC0, CRC, CRS-HIPEC, DFS, HR, IQR, OS, PCI
57  2019 Cytoreductive surgery and heated intraperitoneal chemotherapy for peritoneal carcinomatosis from rare etiologies. CRS/HIPEC, OS
58  2019 Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Carcinomatosis: Multicenter Study of Spanish Group of Peritoneal Oncologic Surgery (GECOP). CI, CRS, DFS, GC, GECOP, HIPEC, HR, OS, PCI
59  2019 Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a patient with peritoneal carcinomatosis from a pancreatic cystadenocarcinoma: A case report. CRS, CT, HIPEC
60  2019 Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: morbidity and postoperative outcomes. CRS, HIPEC
61  2019 Different Features of Tumor-Associated NK Cells in Patients With Low-Grade or High-Grade Peritoneal Carcinomatosis. CRS/HIPEC, PF
62  2019 Differentiation of peritoneal tuberculosis from peritoneal carcinomatosis by the Omental Rim sign. A new sign on contrast enhanced multidetector computed tomography. CT, CT-OR, PTB
63  2019 Diffusion-weighted magnetic resonance imaging in peritoneal carcinomatosis from suspected ovarian cancer: Diagnostic performance in correlation with surgical findings. CT, DP, DWI-MRI, OC, PCI
64  2019 Early postoperative intraperitoneal chemotherapy for lower gastrointestinal neoplasms with peritoneal metastasis: a systematic review and critical analysis. CRS, EPIC, HIPEC
65  2019 Efficacy of postoperative intraperitoneal hyperthermic perfusion chemotherapy with oxaliplatin + 5-Fluorouracil in the treatment of gastric cancer patients with peritoneal carcinomatosis. 5-FU, BUN, IHPC, KPS, SCr
66  2019 Evaluation of Enhanced Recovery After Following a Surgical Protocol for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis. ERAS
67  2019 Exploring the Use of Pegylated Liposomal Doxorubicin (Caelyx) as Pressurized Intraperitoneal Aerosol Chemotherapy. PIPAC, PLD
68  2019 Extended abdominopelvic MRI versus CT at the time of adnexal mass characterization for assessing radiologic peritoneal cancer index (PCI) prior to cytoreductive surgery. PCI
69  2019 Hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal malignancies using new hybrid CO2 system: preliminary experience in referral center. HIPEC
70  2019 Incidence and risk factors for peritoneal carcinomatosis following open radical cystectomy. CSS, IQR, OSS, RC
71  2019 More Synchronous Peritoneal Disease but Longer Survival in Younger Patients with Carcinomatosis from Colorectal Cancer Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. CRC, CRS/HIPEC
72  2019 Overall clinical and trichoscopic analysis performed in patients who underwent pressurized intraperitoneal aerosol chemotherapy (PIPAC) treatment for peritoneal carcinomatosis - initial trial preliminary report. PIPAC
73  2019 Peritoneal Carcinomatosis Diagnosis and Treatment in China: Focusing on Training and Collaboration. CRS, HIPEC
74  2019 Peritoneal carcinomatosis in non-small-cell lung cancer: retrospective multicentric analysis and literature review. NSCLC, OS
75  2019 Peritoneal Carcinomatosis in Well-Differentiated Small-Intestinal Neuroendocrine Tumors with Mesenteric Tumor Deposits. MTDs, SI-NETs
76  2019 Peritoneal carcinomatosis index predicts survival in colorectal patients undergoing HIPEC using oxaliplatin: a retrospective single-arm cohort study. CRS, DFS, HIPEC, PCI
77  2019 Preoperative assessment of splenic involvement in patients with peritoneal carcinomatosis with CT and MR imaging. CRS, CT, HIPEC, MRI
78  2019 Pressurized intraperitoneal aerosol chemotherapy procedure for nonresectable peritoneal carcinomatosis: First Indian study. PIPAC
79  2019 Pretargeted radioimmunotherapy and SPECT imaging of peritoneal carcinomatosis using bioorthogonal click chemistry: probe selection and first proof-of-concept. i.p, PCI, PRIT, TCO, Tz
80  2019 Prevention of Venous Thromboembolism After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Development of a Physiotherapy Program. CRS, HIPEC, VTE
81  2019 Short-term complications in elderly patients undergoing CRS and HIPEC: A single center's initial experience. CRC, CRS, HIPEC, PCI, PMP, SAE
82  2019 Signet ring cell features with peritoneal carcinomatosis in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy are associated with poor overall survival. AC, CRC, CRS/HIPEC, GC, PCI, SRC
83  2019 Sites of Recurrence After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis from Colorectal and Appendiceal Adenocarcinoma: A Tertiary Center Experience. AC, CI, CRC, DFS, HIPEC
84  2019 Status of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer. CRC, CRS, HIPEC
85  2019 Synchronous pancreas and liver resection during CRS HIPEC. Results of 35 consecutive patients. CRS, CT, HIPEC
86  2019 The Current Status of Peritoneal Surface Oncology in Saudi Arabia. CRS, HIPEC
87  2019 The impact of BMI extremes on disease-free survival and overall survival following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. BMI, CRS, DFS, HIPEC, OS, PMP
88  2019 Tumor-sealing Surgical Orthotopic Implantation of Human Colon Cancer in Nude Mice Induces Clinically-relevant Metastases Without Early Peritoneal Carcinomatosis. GFP, SSI, TSM
89  2019 Use of hyperthermia versus normothermia during intraperitoneal chemoperfusion with oxaliplatin for colorectal peritoneal carcinomatosis: A propensity score matched analysis. CCI, CD, HIPEC, OX, PS
90  2019 Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases. CT, DWI, MRI, NPV, PCI, PPV
91  2019 [Factors affecting the survival of patients with peritoneal carcinomatosis of colorectal origin]. CRC, CS, DFS, HIPEC, PCI
92  2019 [Prevention of carcinomatosis in colon cancer]. CRC
93  2018 Analysis of patient selection policy and pattern of recurrence after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal carcinomatosis. CRS, HIPEC
94  2018 Comparative clinicopathological and cytomorphological analyses of peritoneal carcinomatosis associated with metastatic breast carcinoma and primary peritoneal/ovarian carcinoma in patients with a history of breast carcinoma. MBC, PF, PPOC
95  2018 Comparison of Survival in Patients with Isolated Peritoneal Carcinomatosis from Colorectal Cancer Treated with Cytoreduction and Melphalan or Mitomycin-C as Hyperthermic Intraperitoneal Chemotherapy Agent. CRC, HIPEC, OS, PCI, PFS
96  2018 Concentrations of cisplatin and doxorubicin in ascites and peritoneal tumor nodules before and after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal metastasis. PIPAC
97  2018 Could texture features from preoperative CT image be used for predicting occult peritoneal carcinomatosis in patients with advanced gastric cancer? AGC, ROC, ROI
98  2018 Cytoreductive Surgery and Hyperthermic Intraoperative Chemotherapy for Management of Peritoneal Carcinomatosis. CRS, HIPEC, OS
99  2018 Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in ovarian and gastrointestinal peritoneal carcinomatosis: results from a 7-year experience. AC, CRC, CRS, CTCAE, DFS, GC, HIPEC, OC, OS
100  2018 Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with gastric cancer and peritoneal carcinomatosis. CRS, GC, HIPEC, OS